Flotufolastat F-18 Gallium Clinical Trials
7 recruitingOther
Early Phase 13Phase 22Not Applicable2
Showing 1–7 of 7 trials
Recruiting
Not Applicable
Accuracy of 18F-rhPSMA-7.3 PET/ MRI for Prediction of Lymph Node Metastasis in Localized High-Risk Prostate Cancer
Stage III Prostate Cancer AJCC v8Localized Prostate CarcinomaStage I Prostate Cancer AJCC v8+3 more
Mayo Clinic50 enrolled1 locationNCT06389786
Recruiting
Phase 2
Androgen Deprivation Therapy (Relugolix) for the Improvement of Diagnostic Imaging (PSMA PET/CT Scan) in Patients With High Risk or Very High Risk Prostate Cancer, The EnrichPSMA Trial
Stage III Prostate Cancer AJCC v8Stage IV Prostate Cancer AJCC v8Prostate Adenocarcinoma+1 more
Mayo Clinic30 enrolled1 locationNCT07025369
Recruiting
Early Phase 1
Comparing a New PSMA Imaging Agent to MRI for Detecting Prostate Cancer, BEACON Trial
Prostate Carcinoma
Jonsson Comprehensive Cancer Center30 enrolled1 locationNCT07164027
Recruiting
Not Applicable
[18F]-rhPSMA PET-CT Imaging Performance in Patients With Prostate Cancer
Prostate Carcinoma
City of Hope Medical Center20 enrolled1 locationNCT06580015
Recruiting
Phase 2
An Investigational Scan (18F-rhPSMA-7.3 PET-mpMRI) for Targeted Prostate Biopsy Using TRUS-MR Fusion Technique
Prostate Carcinoma
Emory University90 enrolled1 locationNCT06865768
Recruiting
Early Phase 1
rhPSMA-73 PET-MRI Imaging for the Detection of Prostate Cancer Among Men Who Are Otherwise Candidates for Active Surveillance
Prostate AdenocarcinomaStage I Prostate Cancer AJCC v8Stage IIB Prostate Cancer AJCC v8+1 more
Northwestern University40 enrolled1 locationNCT05852041
Recruiting
Early Phase 1
An Investigational Scan (rhPSMA-7.3 PET/CT) for Detecting Biochemically Recurrent Prostate Cancer, ENLIGHTEN Trial
Biochemically Recurrent Prostate CarcinomaProstate Adenocarcinoma
Northwestern University27 enrolled1 locationNCT06813898